CTHRC1 and pancreatic neoplasm: Key in vitro studies were conducted using both primary PSCs and immortalized PSCs to evaluate the potential differences in their responses to CTHRC1 because immortalized PSCs may differ considerably from primary PSCs in terms of their responses to pancreatic cancer cells [18].